While the frequent inactivation of TP53 and RB1 genes in human VN-MCC tumors indicates this will likely be a prerequisite for development of a VN-MCC GEMM, additional drivers or pathway perturbations that might be required are unclear. The gene discussed is TP53; the disease is Merkel cell skin cancer.